InspireMD ROA 2013-2025 | NSPR
Current and historical return on assets (ROA) values for InspireMD (NSPR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| InspireMD ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.05B | $0.08B | -93.40% |
| 2025-06-30 | $-0.04B | $0.03B | -97.04% |
| 2025-03-31 | $-0.04B | $0.04B | -75.00% |
| 2024-12-31 | $-0.03B | $0.05B | -65.64% |
| 2024-09-30 | $-0.03B | $0.05B | -57.14% |
| 2024-06-30 | $-0.03B | $0.06B | -51.02% |
| 2024-03-31 | $-0.02B | $0.04B | -45.36% |
| 2023-12-31 | $-0.02B | $0.05B | -44.19% |
| 2023-09-30 | $-0.02B | $0.05B | -51.01% |
| 2023-06-30 | $-0.02B | $0.05B | -59.84% |
| 2023-03-31 | $-0.02B | $0.02B | -71.70% |
| 2022-12-31 | $-0.02B | $0.03B | -62.81% |
| 2022-09-30 | $-0.02B | $0.03B | -52.94% |
| 2022-06-30 | $-0.02B | $0.03B | -45.03% |
| 2022-03-31 | $-0.02B | $0.04B | -39.02% |
| 2021-12-31 | $-0.02B | $0.04B | -33.71% |
| 2021-09-30 | $-0.02B | $0.04B | -38.46% |
| 2021-06-30 | $-0.01B | $0.05B | -40.31% |
| 2021-03-31 | $-0.01B | $0.05B | -43.56% |
| 2020-12-31 | $-0.01B | $0.02B | -67.80% |
| 2020-09-30 | $-0.01B | $0.02B | -70.59% |
| 2020-06-30 | $-0.01B | $0.02B | -76.60% |
| 2020-03-31 | $-0.01B | $0.01B | -94.74% |
| 2019-12-31 | $-0.01B | $0.01B | -97.56% |
| 2019-09-30 | $-0.01B | $0.01B | -83.72% |
| 2019-06-30 | $-0.01B | $0.01B | -80.00% |
| 2019-03-31 | $-0.01B | $0.01B | -71.11% |
| 2018-12-31 | $-0.01B | $0.01B | -66.67% |
| 2018-09-30 | $-0.01B | $0.01B | -122.22% |
| 2018-06-30 | $-0.01B | $0.01B | -151.72% |
| 2018-03-31 | $-0.01B | $0.01B | -165.52% |
| 2017-12-31 | $-0.01B | $0.01B | -157.58% |
| 2017-09-30 | $-0.01B | $0.01B | -100.00% |
| 2017-06-30 | $-0.01B | $0.01B | -87.80% |
| 2017-03-31 | $-0.01B | $0.01B | -102.86% |
| 2016-12-31 | $-0.01B | $0.01B | -114.29% |
| 2016-09-30 | $-0.01B | $0.01B | -144.00% |
| 2016-06-30 | $-0.01B | $0.00B | -191.30% |
| 2016-03-31 | $-0.01B | $0.00B | -152.94% |
| 2015-12-31 | $-0.02B | $0.01B | -133.33% |
| 2015-09-30 | $-0.02B | $0.01B | -135.85% |
| 2015-06-30 | $-0.02B | $0.01B | -158.49% |
| 2015-03-31 | $-0.03B | $0.02B | -188.68% |
| 2014-12-31 | $-0.03B | $0.01B | -189.09% |
| 2014-06-30 | $-0.02B | $0.01B | -94.74% |
| 2014-03-31 | $-0.03B | $0.02B | -120.48% |
| 2013-06-30 | $-0.03B | $0.02B | -196.49% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.089B | $0.007B |
| InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.426B | 25.84 |
| Intuitive Surgical (ISRG) | United States | $196.987B | 77.07 |
| IDEXX Laboratories (IDXX) | United States | $55.092B | 54.71 |
| Edwards Lifesciences (EW) | United States | $50.080B | 33.58 |
| Alcon (ALC) | Switzerland | $38.300B | 25.88 |
| IQVIA Holdings (IQV) | United States | $37.570B | 20.95 |
| Mettler-Toledo (MTD) | United States | $28.662B | 33.53 |
| STERIS (STE) | Ireland | $25.362B | 26.18 |
| DexCom (DXCM) | United States | $22.644B | 31.22 |
| Waters (WAT) | United States | $22.588B | 29.87 |
| Hologic (HOLX) | United States | $16.492B | 17.37 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.115B | 0.00 |
| Globus Medical (GMED) | United States | $11.303B | 23.72 |
| Penumbra (PEN) | United States | $10.968B | 77.15 |
| Masimo (MASI) | United States | $8.117B | 26.01 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.171B | 0.00 |
| Teleflex (TFX) | United States | $4.729B | 7.54 |
| TransMedics (TMDX) | United States | $3.930B | 46.56 |
| Veracyte (VCYT) | United States | $3.111B | 35.45 |
| LivaNova (LIVN) | United Kingdom | $3.023B | 16.33 |
| Alphatec Holdings (ATEC) | United States | $2.932B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 11.43 |
| Artivion (AORT) | United States | $2.165B | 99.35 |
| Nihon Kohden (NHNKY) | Japan | $2.021B | 17.64 |
| Elekta AB (EKTAY) | Sweden | $1.737B | 16.83 |
| PROCEPT BioRobotics (PRCT) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.197B | 0.00 |
| AxoGen (AXGN) | United States | $1.086B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.12 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.976B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.915B | 4.96 |
| SiBone (SIBN) | United States | $0.756B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.529B | 30.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.55 |
| AngioDynamics (ANGO) | United States | $0.499B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 11.27 |
| RxSight (RXST) | United States | $0.400B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.376B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.331B | 2.49 |
| Delcath Systems (DCTH) | United States | $0.315B | 52.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.315B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.25 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |